Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anti-Mullerian Hormone | 17 | 2025 | 420 | 5.040 |
Why?
|
Ovarian Follicle | 8 | 2022 | 244 | 2.530 |
Why?
|
Receptors, Transforming Growth Factor beta | 6 | 2022 | 306 | 1.720 |
Why?
|
Receptors, Peptide | 6 | 2022 | 280 | 1.690 |
Why?
|
Contraceptive Agents | 2 | 2022 | 148 | 1.210 |
Why?
|
Ovary | 6 | 2025 | 965 | 1.200 |
Why?
|
Granulosa Cells | 5 | 2025 | 121 | 1.190 |
Why?
|
Ovarian Neoplasms | 11 | 2022 | 4919 | 1.110 |
Why?
|
Drug Repositioning | 1 | 2022 | 246 | 0.670 |
Why?
|
Doxorubicin | 2 | 2025 | 2234 | 0.660 |
Why?
|
Mullerian Ducts | 1 | 2019 | 203 | 0.610 |
Why?
|
Fertility Agents, Female | 1 | 2018 | 101 | 0.610 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2017 | 3621 | 0.570 |
Why?
|
Small Molecule Libraries | 1 | 2022 | 742 | 0.530 |
Why?
|
DNA Damage | 2 | 2025 | 2472 | 0.490 |
Why?
|
Uterus | 1 | 2019 | 663 | 0.490 |
Why?
|
Neoplasms, Glandular and Epithelial | 2 | 2016 | 489 | 0.480 |
Why?
|
Protein Isoforms | 2 | 2016 | 1714 | 0.460 |
Why?
|
Superovulation | 1 | 2013 | 11 | 0.440 |
Why?
|
Dependovirus | 2 | 2017 | 721 | 0.440 |
Why?
|
beta Catenin | 1 | 2017 | 1047 | 0.380 |
Why?
|
Kallikreins | 1 | 2011 | 219 | 0.350 |
Why?
|
Fibrinogen | 1 | 2013 | 892 | 0.330 |
Why?
|
Luteinization | 2 | 2022 | 10 | 0.320 |
Why?
|
Placenta | 3 | 2021 | 1725 | 0.290 |
Why?
|
Cell Differentiation | 3 | 2025 | 11684 | 0.270 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2017 | 2893 | 0.270 |
Why?
|
Oocytes | 3 | 2021 | 1172 | 0.260 |
Why?
|
Pregnancy Complications, Infectious | 4 | 2021 | 2190 | 0.260 |
Why?
|
Tissue Array Analysis | 3 | 2016 | 551 | 0.250 |
Why?
|
Transcription Factors | 3 | 2013 | 12174 | 0.250 |
Why?
|
Fetal Blood | 2 | 2021 | 1361 | 0.230 |
Why?
|
Adenosine Triphosphatases | 1 | 2007 | 842 | 0.210 |
Why?
|
DNA-Binding Proteins | 2 | 2013 | 9618 | 0.210 |
Why?
|
RNA, Satellite | 1 | 2022 | 16 | 0.210 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2007 | 633 | 0.210 |
Why?
|
Anthracenes | 1 | 2022 | 83 | 0.200 |
Why?
|
Mice | 14 | 2025 | 82072 | 0.190 |
Why?
|
Cell Line, Tumor | 7 | 2022 | 17173 | 0.180 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2025 | 682 | 0.180 |
Why?
|
alpha-Fetoproteins | 1 | 2021 | 229 | 0.170 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2020 | 112 | 0.170 |
Why?
|
Follicular Fluid | 1 | 2020 | 92 | 0.170 |
Why?
|
Receptors, Nicotinic | 1 | 2023 | 494 | 0.170 |
Why?
|
Lysophospholipids | 1 | 2022 | 338 | 0.170 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2025 | 2960 | 0.170 |
Why?
|
Animals | 18 | 2025 | 169335 | 0.170 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2021 | 1360 | 0.170 |
Why?
|
Cell Proliferation | 5 | 2021 | 10486 | 0.170 |
Why?
|
Serine Endopeptidases | 2 | 2021 | 1027 | 0.160 |
Why?
|
Phosphoproteins | 2 | 2020 | 2452 | 0.160 |
Why?
|
Antineoplastic Agents | 4 | 2017 | 13698 | 0.160 |
Why?
|
Antibodies, Viral | 2 | 2020 | 3215 | 0.160 |
Why?
|
Female | 29 | 2025 | 397515 | 0.160 |
Why?
|
Exons | 2 | 2016 | 2395 | 0.160 |
Why?
|
Dystocia | 1 | 2018 | 36 | 0.160 |
Why?
|
Caspase 3 | 1 | 2021 | 731 | 0.150 |
Why?
|
Maternal-Fetal Exchange | 1 | 2020 | 456 | 0.150 |
Why?
|
Interferon Type I | 1 | 2022 | 569 | 0.150 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2020 | 329 | 0.150 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2022 | 8664 | 0.140 |
Why?
|
DNA Repair | 2 | 2025 | 2054 | 0.140 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2022 | 1340 | 0.140 |
Why?
|
Estrogen Receptor alpha | 1 | 2021 | 581 | 0.140 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2017 | 5342 | 0.140 |
Why?
|
Nitriles | 1 | 2022 | 990 | 0.140 |
Why?
|
Embryo Transfer | 1 | 2020 | 527 | 0.130 |
Why?
|
Primary Ovarian Insufficiency | 1 | 2017 | 108 | 0.130 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2021 | 859 | 0.130 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2020 | 480 | 0.130 |
Why?
|
Neoplastic Stem Cells | 2 | 2016 | 1356 | 0.130 |
Why?
|
Tropism | 1 | 2015 | 44 | 0.130 |
Why?
|
Smad Proteins | 1 | 2016 | 157 | 0.120 |
Why?
|
Activin Receptors, Type I | 1 | 2016 | 134 | 0.120 |
Why?
|
Apoptosis | 2 | 2025 | 9527 | 0.120 |
Why?
|
Immunoassay | 1 | 2018 | 746 | 0.120 |
Why?
|
Thiazoles | 1 | 2022 | 1542 | 0.120 |
Why?
|
Fertility | 1 | 2019 | 771 | 0.120 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2018 | 383 | 0.110 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2014 | 70 | 0.110 |
Why?
|
Spheroids, Cellular | 1 | 2015 | 331 | 0.110 |
Why?
|
Ascites | 1 | 2015 | 338 | 0.110 |
Why?
|
Cryopreservation | 1 | 2018 | 734 | 0.110 |
Why?
|
Contraception | 1 | 2017 | 362 | 0.110 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2013 | 104 | 0.100 |
Why?
|
Fertilization in Vitro | 1 | 2020 | 1303 | 0.100 |
Why?
|
Cell Movement | 2 | 2017 | 5216 | 0.100 |
Why?
|
Reproduction | 1 | 2017 | 646 | 0.100 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2014 | 368 | 0.100 |
Why?
|
Immunoglobulin G | 2 | 2020 | 4568 | 0.100 |
Why?
|
Transgenes | 1 | 2015 | 1016 | 0.100 |
Why?
|
Pyrimidines | 2 | 2022 | 3048 | 0.100 |
Why?
|
Phosphorylation | 2 | 2021 | 8317 | 0.090 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22379 | 0.090 |
Why?
|
Cisplatin | 1 | 2017 | 1661 | 0.090 |
Why?
|
Pyrazoles | 1 | 2022 | 2029 | 0.090 |
Why?
|
Humans | 27 | 2025 | 768970 | 0.090 |
Why?
|
Chorionic Gonadotropin | 1 | 2013 | 458 | 0.090 |
Why?
|
Alternative Splicing | 1 | 2016 | 1105 | 0.090 |
Why?
|
Cell Survival | 1 | 2021 | 5793 | 0.090 |
Why?
|
Mass Spectrometry | 1 | 2018 | 2204 | 0.090 |
Why?
|
Muscles | 1 | 2015 | 1582 | 0.090 |
Why?
|
RNA, Small Interfering | 2 | 2017 | 3433 | 0.090 |
Why?
|
Immunoconjugates | 1 | 2017 | 976 | 0.080 |
Why?
|
Gene Expression Regulation | 2 | 2016 | 11932 | 0.080 |
Why?
|
Mice, Nude | 2 | 2017 | 3631 | 0.080 |
Why?
|
Cesarean Section | 1 | 2018 | 1426 | 0.080 |
Why?
|
Hedgehog Proteins | 1 | 2014 | 771 | 0.080 |
Why?
|
Tumor Burden | 1 | 2015 | 1913 | 0.080 |
Why?
|
Cell Count | 1 | 2013 | 1833 | 0.080 |
Why?
|
Endothelial Cells | 1 | 2022 | 3592 | 0.080 |
Why?
|
RNA Interference | 1 | 2017 | 2835 | 0.080 |
Why?
|
Base Sequence | 1 | 2019 | 12430 | 0.080 |
Why?
|
Tumor Cells, Cultured | 2 | 2016 | 6131 | 0.070 |
Why?
|
Mice, Transgenic | 3 | 2020 | 9565 | 0.070 |
Why?
|
Sex Factors | 1 | 2021 | 10633 | 0.070 |
Why?
|
Progesterone | 2 | 2023 | 752 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 1 | 2015 | 3744 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2017 | 2911 | 0.070 |
Why?
|
Premature Birth | 1 | 2018 | 1830 | 0.070 |
Why?
|
Nanoparticles | 1 | 2017 | 1989 | 0.060 |
Why?
|
Rats | 1 | 2022 | 23786 | 0.060 |
Why?
|
Meiosis | 1 | 2007 | 327 | 0.060 |
Why?
|
Cell Adhesion | 1 | 2011 | 3102 | 0.060 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2022 | 755 | 0.060 |
Why?
|
Pregnancy | 6 | 2021 | 30265 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3813 | 0.060 |
Why?
|
Cell Nucleus | 1 | 2013 | 2885 | 0.060 |
Why?
|
Epithelial Cells | 1 | 2016 | 3702 | 0.060 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2014 | 2059 | 0.060 |
Why?
|
Fetus | 2 | 2021 | 1882 | 0.060 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2006 | 859 | 0.050 |
Why?
|
Estradiol | 2 | 2021 | 1952 | 0.050 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9549 | 0.050 |
Why?
|
Signal Transduction | 4 | 2016 | 23653 | 0.050 |
Why?
|
Receptors, Lysophosphatidic Acid | 1 | 2022 | 78 | 0.050 |
Why?
|
Receptors, Progesterone | 1 | 2006 | 1159 | 0.050 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18354 | 0.050 |
Why?
|
Adult | 8 | 2021 | 223851 | 0.050 |
Why?
|
Infant, Newborn | 4 | 2021 | 26428 | 0.040 |
Why?
|
Activin Receptors, Type II | 1 | 2020 | 123 | 0.040 |
Why?
|
Oocyte Retrieval | 1 | 2020 | 162 | 0.040 |
Why?
|
Glioblastoma | 1 | 2014 | 3525 | 0.040 |
Why?
|
Prognosis | 2 | 2018 | 30046 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2022 | 3952 | 0.040 |
Why?
|
Uterine Inertia | 1 | 2018 | 29 | 0.040 |
Why?
|
Indicator Dilution Techniques | 1 | 2018 | 43 | 0.040 |
Why?
|
Gene Expression | 2 | 2021 | 7603 | 0.040 |
Why?
|
Isotopes | 1 | 2018 | 125 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 1 | 2020 | 586 | 0.040 |
Why?
|
Caseins | 1 | 2018 | 105 | 0.040 |
Why?
|
Endocrine Disruptors | 1 | 2021 | 265 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2014 | 5707 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2013 | 19023 | 0.040 |
Why?
|
Receptors, IgG | 1 | 2020 | 564 | 0.040 |
Why?
|
Pregnancy Rate | 1 | 2020 | 655 | 0.040 |
Why?
|
Survival Rate | 1 | 2011 | 12873 | 0.040 |
Why?
|
Influenza A virus | 1 | 2020 | 460 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2020 | 1683 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2021 | 1866 | 0.030 |
Why?
|
Bone Morphogenetic Protein Receptors, Type II | 1 | 2016 | 72 | 0.030 |
Why?
|
Calibration | 1 | 2018 | 822 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2020 | 1528 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 1003 | 0.030 |
Why?
|
Melanoma | 1 | 2014 | 5709 | 0.030 |
Why?
|
Phenotype | 2 | 2023 | 16731 | 0.030 |
Why?
|
Aged | 3 | 2016 | 171786 | 0.030 |
Why?
|
Topotecan | 1 | 2014 | 131 | 0.030 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2014 | 108 | 0.030 |
Why?
|
Estrogens | 1 | 2021 | 1536 | 0.030 |
Why?
|
Survival Analysis | 2 | 2017 | 10115 | 0.030 |
Why?
|
Radiation, Ionizing | 1 | 2014 | 252 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2016 | 59739 | 0.030 |
Why?
|
Gene Deletion | 1 | 2021 | 2674 | 0.030 |
Why?
|
Middle Aged | 3 | 2016 | 223737 | 0.030 |
Why?
|
RNA | 1 | 2022 | 2727 | 0.030 |
Why?
|
Heat-Shock Proteins | 1 | 2016 | 797 | 0.030 |
Why?
|
RNA, Viral | 1 | 2020 | 2871 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2016 | 13594 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 615 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3398 | 0.020 |
Why?
|
Mice, SCID | 1 | 2016 | 2631 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4290 | 0.020 |
Why?
|
G1 Phase | 1 | 2012 | 403 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6320 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3914 | 0.020 |
Why?
|
Biphenyl Compounds | 1 | 2014 | 1026 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2017 | 6232 | 0.020 |
Why?
|
Benzimidazoles | 1 | 2014 | 864 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 2004 | 0.020 |
Why?
|
Benzamides | 1 | 2014 | 1387 | 0.020 |
Why?
|
Quinazolines | 1 | 2014 | 1373 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2023 | 14484 | 0.020 |
Why?
|
Pyrroles | 1 | 2014 | 1125 | 0.020 |
Why?
|
NF-kappa B | 1 | 2016 | 2492 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1505 | 0.020 |
Why?
|
Cadherins | 1 | 2012 | 906 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2021 | 7609 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2014 | 1495 | 0.020 |
Why?
|
Cell Cycle | 1 | 2014 | 2937 | 0.020 |
Why?
|
Male | 3 | 2021 | 365203 | 0.020 |
Why?
|
Indoles | 1 | 2014 | 1836 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2016 | 1672 | 0.020 |
Why?
|
Piperidines | 1 | 2014 | 1667 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 2460 | 0.020 |
Why?
|
Up-Regulation | 1 | 2014 | 4148 | 0.010 |
Why?
|
Sulfonamides | 1 | 2014 | 1981 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2014 | 5906 | 0.010 |
Why?
|
Piperazines | 1 | 2014 | 2553 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22296 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15951 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 6086 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8559 | 0.010 |
Why?
|
Pyridines | 1 | 2014 | 2895 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8749 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11262 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2020 | 81903 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41808 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5434 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 54962 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 11886 | 0.010 |
Why?
|
Child | 1 | 2021 | 80960 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2017 | 65480 | 0.010 |
Why?
|